PI3K/AKT and MEK/ERK pathways targeted in new therapy for docetaxel-resistant prostate cancer news-medical.net, 05 Feb 2024 A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumours Unit of the…